AbbVie Inc. will keep Allergan PLC’s market-leading medical aesthetics business in the hands of Allergan employees who know how to develop and market products in this unique biopharmaceutical and medical device category after the big pharma closes its $63bn acquisition of the specialty firm in the first quarter of 2020.
Allergan senior vice president of US medical aesthetics Carrie Strom will become a senior vice present at AbbVie and president...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?